Point of care sepsis diagnosis: Exploring microfluidic techniques for sample preparation, biomarker isolation, and detection
- 1 July 2025
- journal article
- review article
- Published by AIP Publishing in Biomicrofluidics
- Vol. 19 (4) , 041502
Abstract
According to the third international consensus definition (sepsis-3), sepsis is defined as life-threatening organ dysfunction resulting from an uncontrolled host response to infection. Sepsis remains a leading cause of global mortality, largely due to the difficulty of achieving a timely diagnosis. The conventional diagnostic approaches for sepsis often face limitations in speed, portability, sensitivity, and specificity, which can lead to delayed or missed diagnoses. In response, microfluidic devices have emerged as powerful tools for point-of-care precise sample handling and preparation, enabling efficient isolation and detection of sepsis-causing bacteria and biomarkers. Fabrication techniques of these microfluidic devices, ranging from photolithography to xurography, have significantly advanced and paved the way for complex designs and improved functionality. Microfluidic platforms offer various benefits in sepsis diagnosis and prognosis. They facilitate rapid and automated sample processing, enhancing turnaround times and reducing the risk of contamination. Moreover, the integration of microfluidic systems with advanced detection methods enables the simultaneous analysis of multiple biomarkers, thereby enhancing diagnostic accuracy and prognostic capabilities. This review explores the evolution of sepsis diagnosis from traditional lab based methods to the use of microfluidic technology that can facilitate point of care diagnostics and discusses emerging trends in this field.Keywords
Funding Information
- Ontario Research Fund Federal Development Ontario Fund
- Natural Sciences and Engineering Research Council of Canada
This publication has 172 references indexed in Scilit:
- Sepsis biomarkers: a reviewCritical Care, 2010
- Comparison of C‐Reactive Protein and Serum Amyloid A Protein in Septic Shock PatientsMediators of Inflammation, 2008
- Point of Care TestingClinics In Laboratory Medicine, 2007
- Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shockEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settingsThe Lancet Infectious Diseases, 2004
- Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patientsCritical Care, 2003
- Gray-scale photolithography using microfluidic photomasksProceedings of the National Academy of Sciences, 2003
- Immunoluminometric detection of human procalcitoninJournal of Biochemical and Biophysical Methods, 2002
- Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2001